Nejat, R. et al. 2021. Losartan Inhibits SARS-CoV-2 Replication in Vitro: Losartan promotes cell survival following SARS-CoV-2 infection in vitro. Journal of Pharmacy & Pharmaceutical Sciences. 24, 3 (Jul. 2021), 390–399. DOI:https://doi.org/10.18433/jpps31931.